Five Prime Therapeutics, Inc
Amgen harnesses biology and technology to fight serious diseases, aiming to make people's lives easier, fuller, and longer. With a history of over 40 years in biotechnology, Amgen is committed to innovation, research, and development of medicines across various therapeutic areas including cancer, heart disease, osteoporosis, inflammation, and rare diseases. The company operates globally, reaching millions of patients, and emphasizes responsible operation, sustainability, and diversity. Recognized as a leading biotech company, Amgen is part of major indices like the Dow Jones Industrial Average and Nasdaq-100, and has received numerous awards for its innovation, responsibility, and workplace excellence.
Industries
Nr. of Employees
medium (51-250)
Five Prime Therapeutics, Inc
One Amgen Center Drive, Thousand Oaks, CA 91320, USA
Patents
Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer
US-12319738-B2
View Details
Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer
US-12319738-B2
View DetailsProducts
Monoclonal antibody therapies
Therapeutic monoclonal antibodies developed for oncology, inflammation, bone health and other indications.
Small‑molecule and synthetic drug products
Commercial small‑molecule therapeutics produced via chemical synthesis processes.
Biosimilars
Therapeutic biosimilar products developed and manufactured for regulatory approval in multiple markets.
Drug‑delivery systems (on‑body injectors and prefilled cartridges)
Integrated delivery devices and prefilled formats designed to enable home or ambulatory administration of biologic medicines.
Monoclonal antibody therapies
Therapeutic monoclonal antibodies developed for oncology, inflammation, bone health and other indications.
Small‑molecule and synthetic drug products
Commercial small‑molecule therapeutics produced via chemical synthesis processes.
Biosimilars
Therapeutic biosimilar products developed and manufactured for regulatory approval in multiple markets.
Drug‑delivery systems (on‑body injectors and prefilled cartridges)
Integrated delivery devices and prefilled formats designed to enable home or ambulatory administration of biologic medicines.
Services
Commercial‑scale production and process development for biologic therapeutics, including upstream and downstream operations and facility deployment.
Collaborative development and commercialization agreements for biosimilar therapeutics, including manufacturing and regulatory support.
Support for clinical trial planning and execution, including study design optimization, diversity initiatives and data‑transparency practices.
Cross‑functional governance and assurance activities for AI systems, covering model validation, explainability, bias mitigation, privacy controls and security measures aligned to trustworthy‑AI principles.
Assessment and planning to identify biodiversity and environmental risks in facility operations and supply chains, and implementation of sustainability practices in manufacturing and sourcing.
Commercial‑scale production and process development for biologic therapeutics, including upstream and downstream operations and facility deployment.
Collaborative development and commercialization agreements for biosimilar therapeutics, including manufacturing and regulatory support.
Support for clinical trial planning and execution, including study design optimization, diversity initiatives and data‑transparency practices.
Cross‑functional governance and assurance activities for AI systems, covering model validation, explainability, bias mitigation, privacy controls and security measures aligned to trustworthy‑AI principles.
Assessment and planning to identify biodiversity and environmental risks in facility operations and supply chains, and implementation of sustainability practices in manufacturing and sourcing.
Expertise Areas
- Biologics discovery and development
- Biomanufacturing and CMC scale‑up
- Clinical trial design and operations
- Biosimilar development
Key Technologies
- Cell‑based biologics production
- Human genetics and population genomics
- Generative biology and machine learning for discovery
- Trustworthy AI frameworks and explainable AI
News & Updates
Amgen presented results from its Phase 2 obesity study of Monthly MariTide at the ADA 85th Scientific Sessions.
Amgen was recognized as one of the world's greenest companies by Newsweek in 2025.
Amgen's culture fosters innovation and has received recognition for its talent and scientific contributions.
Amgen reported strong financial results for Q1 2025.
Amgen scientists draw inspiration from nature to create new molecules that redefine drug development.
Barry Sanders discusses LDL-C and heart attack risk in a new film sponsored by Amgen.
Amgen presented results from its Phase 2 obesity study of Monthly MariTide at the ADA 85th Scientific Sessions.
Amgen was recognized as one of the world's greenest companies by Newsweek in 2025.
Amgen's culture fosters innovation and has received recognition for its talent and scientific contributions.
Amgen reported strong financial results for Q1 2025.
Amgen scientists draw inspiration from nature to create new molecules that redefine drug development.
Barry Sanders discusses LDL-C and heart attack risk in a new film sponsored by Amgen.